ACRX 60% then 300% PROFIT beats the 1% a day
Updated
Previous ratios support the drug success at a return to 10.35, with the pivot mark being at 60% gain.
Comment
August28
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.